Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 301



Status:Terminated
Conditions:Fibromyalgia, Pain
Therapuetic Areas:Musculoskeletal, Rheumatology
Healthy:No
Age Range:22 - 65
Updated:4/21/2016
Start Date:July 2014
End Date:February 2015

Use our guide to learn which trials are right for you!

A Double-Blinded, Randomized, Sham-Controlled, Pivotal Study of the NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia

The purpose of this study is to test the safety and efficacy of a noninvasive cortical
electrostimulation therapy known as "Reduced Impedance Noninvasive Cortical
Electrostimulation" (RINCE) in the treatment of pain associated with fibromyalgia. Patients
who meet the 2010 American College of Rheumatology criteria for fibromyalgia will receive up
to 24 RINCE treatments delivered by a medical device called "NeuroPoint". Approximately 200
fibromyalgia patients will be randomized into one of two study groups. One of these groups
will receive sham treatment, meaning they will receive no treatment at all, while the other
group will receive active RINCE treatment. The study's primary outcome measure will be the
difference between active and sham treatment groups in the mean change from baseline in
patients' weekly worst pain scores. The study's hypothesis is that there will be a
difference between treatment groups in primary outcome measure.


Inclusion Criteria:

- Patient is male or female, 22 to 65 years of age, inclusive.

- Patient has a diagnosis of primary fibromyalgia as defined by the 2010 American
College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia.

- If female, is either not of childbearing potential or is willing to utilize specified
practices throughout the study to prevent becoming pregnant.

- Patient is willing and able to refrain or withdraw from the following therapies for
the duration of the study: duloxetine, milnacipran, pregabalin, gabapentin,
naltrexone, sodium oxybate, and opiates.

- Qualified patients with mild or moderate depression must be clinically stable,
without risk of suicidal ideation or behavior, and the dose of allowed
anti-depressants should have been stable for at least three months prior to the
Baseline clinic visit.

- Patient is willing and able to comply with all protocol-specified requirements.

- Patient is capable of reading and understanding English and has provided written
informed consent to participate.

Exclusion Criteria:

- The patient suffers from one or more of clinically significant psychiatric condition
that could interfere with the patient's well-being or ability to comply with the
protocol.

- Patient has a Beck Depression Inventory-II total score greater than 25 at either the
Screening visit or Baseline clinic visit.

- The patient is at increased risk of suicide.

- Patient is unable, unwilling or not advised to refrain from or discontinue prohibited
medications or treatments.

- Patient has a diagnosis of, or is being treated for, systemic lupus erythematosus,
inflammatory arthritis, or other documented systemic autoimmune disorder, Parkinson's
disease, multiple sclerosis, or cancer (other than basal or squamous cell skin
cancer).

- Patient has any other chronic pain condition that, in the Investigator's or Sponsor's
opinion, could interfere with the patient's assessment of his/her fibromyalgia
status.

- Patient has a history of severe, refractory or uncontrolled migraine headaches,
seizure disorder or clinically significant cognitive dysfunction.

- Patient is pregnant or planning to become pregnant within the next 6 months.

- Patient has a body mass index greater than 40 at the Screening visit.

- Patient has a history of cranial electrical stimulation or transcutaneous magnetic
stimulation within 2 years of screening, or electroconvulsive therapy within 5 years
of screening.

- Patient has a metal implant at or above the level of the 7th cervical vertebra, a
cardiac pacemaker or defibrillator, or vagus nerve stimulator.

- Any recent surgery or anticipated need for surgery that might confound results or
interfere with patient's ability to comply with the protocol.

- Myocardial infarction during the 12 months prior to screening, uncontrolled
hypertension, active cardiac disease, clinically significant cardiac rhythm or
conduction abnormality, or anticipation of bypass or other cardiac surgery within the
next 12 months.

- Current systemic infection (e.g., HIV, hepatitis B or C; Lyme disease).

- Patient is using opiates on a regular or frequent basis.

- Pending or current litigation or disability claim (including Workman's Compensation).

- History of significant alcohol and/or drug abuse or dependency within preceding 5
years, or a positive result on the screening (or subsequent) drug screen indicating
use of an illicit substance.

- Patient has participated in an investigational study of a therapeutic treatment
within 90 days prior to Screening visit or is currently participating in another
clinical trial.
We found this trial at
16
sites
New York, New York 10168
?
mi
from
New York, NY
Click here to add this to my saved trials
2017 Canyon Road, Suite 41
Birmingham, Alabama 35216
(205) 757-8208
Site Overview Achieve has two clinical research sites in Birmingham, AL. Our Birmingham sites are conveniently located...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
860 Peachwood Drive
DeLand, Florida 32720
(386) 740-0770
Site Overview Avail Clinical Research is a renowned and experienced clinical research site conducting Phase...
?
mi
from
DeLand, FL
Click here to add this to my saved trials
1904 East Barnett Road
Medford, Oregon 97504
541-973-2080
?
mi
from
Medford, OR
Click here to add this to my saved trials
100 West Gore St # 202
Orlando, Florida 32806
(407) 426-9299
Compass Research LLC Compass Research is a clinical research company dedicated to testing new medications...
?
mi
from
Orlando, FL
Click here to add this to my saved trials
400 Bald Hill Road
Warwick, Rhode Island 02886
401-739-9350
?
mi
from
Warwick, RI
Click here to add this to my saved trials
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chicago, Illinois 60634
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Napa, California 94558
?
mi
from
Napa, CA
Click here to add this to my saved trials
Phoenix, Arizona 85027
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Sacramento, California 95825
?
mi
from
Sacramento, CA
Click here to add this to my saved trials
Salt Lake City, Utah 84102
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
San Diego, California 92123
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Seattle, Washington 98122
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Williamsville, New York 14221
?
mi
from
Williamsville, NY
Click here to add this to my saved trials